Ascend Wellness Holdings, Inc. (OTC:AAWH – Free Report) – Cormark analysts lowered their 2024 earnings estimates for shares of Ascend Wellness in a research note on Wednesday, May 8th. Cormark analyst J. Pitrak now expects the company to report full-year earnings per share of ($0.27), down from his previous estimate ($0.23). Ascend Wellness’s current consensus estimate for full-year earnings is ($0.17) per share.
Separately, Needham & Company LLC reiterated a “hold” rating on shares of Ascend Wellness in a research note on Tuesday, May 7th.
Read our latest analysis for Ascend Wellness
Ascend Wellness trades down 1.5%
OTC AAWH began trading at $1.30 on Monday. The company has a quick ratio of 1.44, a current ratio of 2.24, and a debt-to-equity ratio of 2.13. The company has a market capitalization of $268.7 million, a P/E ratio of -5.65, and a beta of 1.95. The company’s 50-day moving average price is $1.27 and its 200-day moving average price is $1.27. Ascend Wellness has a 52-week low of $0.46 and a 52-week high of $1.82.
About Ascend Wellness
(Get Free Report)
Ascend Wellness Holdings, Inc is engaged in the cultivation, manufacturing and distribution of cannabis consumer packaged goods in the United States. The company sells flower, pre-rolls, concentrates, vapes, edibles, tinctures and other cannabis products under Common Goods, Simply Herbs, Ozone, Ozone Reserve, Royal, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, and 1906. We provide related products. , AiroPro brand.
Featured Stories
Receive daily Ascend Wellness news and reviews – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for Ascend Wellness and related companies in MarketBeat.com’s free daily email newsletter.
